418 related articles for article (PubMed ID: 20333625)
1. Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A.
Joffre OP; Sancho D; Zelenay S; Keller AM; Reis e Sousa C
Eur J Immunol; 2010 May; 40(5):1255-65. PubMed ID: 20333625
[TBL] [Abstract][Full Text] [Related]
2. Cross-presentation of dead-cell-associated antigens by DNGR-1
Balam S; Kesselring R; Eggenhofer E; Blaimer S; Evert K; Evert M; Schlitt HJ; Geissler EK; van Blijswijk J; Lee S; Reis e Sousa C; Brunner SM; Fichtner-Feigl S
Eur J Immunol; 2020 Dec; 50(12):2041-2054. PubMed ID: 32640051
[TBL] [Abstract][Full Text] [Related]
3. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.
Idoyaga J; Lubkin A; Fiorese C; Lahoud MH; Caminschi I; Huang Y; Rodriguez A; Clausen BE; Park CG; Trumpfheller C; Steinman RM
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2384-9. PubMed ID: 21262813
[TBL] [Abstract][Full Text] [Related]
4. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.
Sancho D; Mourão-Sá D; Joffre OP; Schulz O; Rogers NC; Pennington DJ; Carlyle JR; Reis e Sousa C
J Clin Invest; 2008 Jun; 118(6):2098-110. PubMed ID: 18497879
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3(-/-) mice.
Caminschi I; Vremec D; Ahmet F; Lahoud MH; Villadangos JA; Murphy KM; Heath WR; Shortman K
Mol Immunol; 2012 Feb; 50(1-2):9-17. PubMed ID: 22209163
[TBL] [Abstract][Full Text] [Related]
6. DNGR-1 is dispensable for CD8+ T-cell priming during respiratory syncytial virus infection.
Durant LR; Pereira C; Boakye A; Makris S; Kausar F; Goritzka M; Johansson C
Eur J Immunol; 2014 Aug; 44(8):2340-8. PubMed ID: 24777856
[TBL] [Abstract][Full Text] [Related]
7. Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy.
Zeng B; Middelberg AP; Gemiarto A; MacDonald K; Baxter AG; Talekar M; Moi D; Tullett KM; Caminschi I; Lahoud MH; Mazzieri R; Dolcetti R; Thomas R
J Clin Invest; 2018 May; 128(5):1971-1984. PubMed ID: 29485973
[TBL] [Abstract][Full Text] [Related]
8. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice.
Zelenay S; Keller AM; Whitney PG; Schraml BU; Deddouche S; Rogers NC; Schulz O; Sancho D; Reis e Sousa C
J Clin Invest; 2012 May; 122(5):1615-27. PubMed ID: 22505458
[TBL] [Abstract][Full Text] [Related]
9. Induction of CTL and nonpolarized Th cell responses by CD8alpha(+) and CD8alpha(-) dendritic cells.
Schlecht G; Leclerc C; Dadaglio G
J Immunol; 2001 Oct; 167(8):4215-21. PubMed ID: 11591742
[TBL] [Abstract][Full Text] [Related]
10. Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall.
Kato Y; Zaid A; Davey GM; Mueller SN; Nutt SL; Zotos D; Tarlinton DM; Shortman K; Lahoud MH; Heath WR; Caminschi I
J Immunol; 2015 Aug; 195(3):1006-14. PubMed ID: 26101322
[TBL] [Abstract][Full Text] [Related]
11. DNGR-1, a Dendritic Cell-Specific Sensor of Tissue Damage That Dually Modulates Immunity and Inflammation.
Cueto FJ; Del Fresno C; Sancho D
Front Immunol; 2019; 10():3146. PubMed ID: 32117205
[TBL] [Abstract][Full Text] [Related]
12. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.
Price JD; Beauchamp NM; Rahir G; Zhao Y; Rieger CC; Lau-Kilby AW; Tarbell KV
J Leukoc Biol; 2014 Feb; 95(2):325-36. PubMed ID: 24082013
[TBL] [Abstract][Full Text] [Related]
13. H2-M3-restricted CD8+ T cells augment CD4+ T-cell responses by promoting DC maturation.
Chow MT; Teh HS
Eur J Immunol; 2010 May; 40(5):1408-17. PubMed ID: 20162552
[TBL] [Abstract][Full Text] [Related]
14. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice.
Iborra S; Izquierdo HM; Martínez-López M; Blanco-Menéndez N; Reis e Sousa C; Sancho D
J Clin Invest; 2012 May; 122(5):1628-43. PubMed ID: 22505455
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.
Poulin LF; Salio M; Griessinger E; Anjos-Afonso F; Craciun L; Chen JL; Keller AM; Joffre O; Zelenay S; Nye E; Le Moine A; Faure F; Donckier V; Sancho D; Cerundolo V; Bonnet D; Reis e Sousa C
J Exp Med; 2010 Jun; 207(6):1261-71. PubMed ID: 20479117
[TBL] [Abstract][Full Text] [Related]
16. CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo.
Wang Z; Davies JD
Int Immunopharmacol; 2007 Feb; 7(2):249-65. PubMed ID: 17178393
[TBL] [Abstract][Full Text] [Related]
17. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
Adams EW; Ratner DM; Seeberger PH; Hacohen N
Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
[TBL] [Abstract][Full Text] [Related]
19. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.
Cueto FJ; Del Fresno C; Brandi P; Combes AJ; Hernández-García E; Sánchez-Paulete AR; Enamorado M; Bromley CP; Gomez MJ; Conde-Garrosa R; Mañes S; Zelenay S; Melero I; Iborra S; Krummel MF; Sancho D
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33980589
[TBL] [Abstract][Full Text] [Related]
20. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
